Vantage Oncology

company

About

Vantage Oncology, Inc., offers a comprehensive development, implementation and management solution for radiation oncology.

  • 501 - 1000

Details

Last Funding Type
Series C
Last Funding Money Raised
$22M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
May 1, 2002
Number Of Employee
501 - 1000
Operating Status
Active

Vantage Oncology, Inc., offers a comprehensive development, implementation and management solution for radiation oncology. The company was created in response to the growing need among cancer patients, hospitals and physicians for accessible and advanced radiation treatment therapies. Vantage encourages joint venture ownership opportunities that empower physicians to maintain control of their practice while leveraging the strength of the company's network. Vantage also provides joint venture ownership opportunities for hospitals interested in maximizing the significant benefits created by a strong radiation oncology department.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$74.50M
Vantage Oncology has raised a total of $74.50M in funding over 2 rounds. Their latest funding was raised on Feb 7, 2007 from a Series D round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 7, 2007 Series D $22.50M 2 Detail
Aug 28, 2006 Series C $6M 1 Detail
May 10, 2005 Series C $22M 2 Conning Capital Partners Detail
Jun 23, 2004 Series B $15M 2 Detail
Nov 6, 2002 Series A $9M 2 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Vantage Oncology is funded by 2 investors. Conning Capital Partners and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Conning Capital Partners Series D
Versant Ventures Series D